Adam Williams | Director, mRNA Commercial Strategy
Pfizer

Adam Williams, Director, mRNA Commercial Strategy, Pfizer

Adam Williams is currently Director, mRNA Commercial Strategy & Innovation at Pfizer, leading strategic efforts in global pandemic security, planning for a broad array of defenses, and driving Pfizer’s thought leadership in preparedness. Adam previously led strategy and market intelligence at CSL Seqirus, including global, cross-functional commercial strategy projects, competitive intelligence, market research, and new product planning. Previously he led the immunization practice at Rabin Martin, a global health consultancy focused on public health policies and programs, and focused on introduction of new vaccines in low- and middle-income countries with the Clinton Health Access Initiative (CHAI) and Axios International. Adam holds a Master of Science in Public Health (MSPH) with a concentration in Global Disease Epidemiology and Control (GDEC) from the Johns Hopkins Bloomberg School of Public Health and a BSc/BA, Biochemistry/Biology from the University of Virginia.

Appearances:



Day 2 - World Antimicrobial Resistance Congress & Disease Prevention Control Summit 2024 @ 11:40

Presentation: What’s next? Predicting and preparing for the next pandemic

last published: 12/Jun/24 19:45 GMT
last published: 12/Jun/24 19:45 GMT

back to speakers


GET INVOLVED AT THE

WORLD ANTIMICROBIAL RESISTANCE CONGRESS

 

To Sponsor Or Exhibit

 


Justin Franks

justin.franks@terrapinn.com
+1 914 819 3506

 

To Speak


Kaylee Nguyen

kaylee.nguyen@terrapinn.com

 

 

Press & Media Partnerships

 


Kaylie Brogan

kaylie.brogan@terrapinn.com

 

 

Start-Ups & Posters

 


Semen Sen

semen.sen@terrapinn.com
+1 646.619.1793